NFKB1 and esophageal squamous cell carcinoma: Our data indicated that inhibition of NF-κB pathway by Bay11-7082 (Figure 4A, B), DNMIκBα (Figure 4C, D) or NF-κB subunit siRNA (Figure 6) attenuates Mcl-1 expression in human ESCC cells.